PharmaEssentia Appoints Robert Geller, M.D. as Head of Medical and Shawn Gibbs, J.D. as Head of Legal
BURLINGTON, Mass.--(BUSINESS WIRE)--Apr 23, 2024--
Source: eagletribune.com
📰 Optimer Pharmaceuticals News
Optimer Pharmaceuticals News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Optimer Pharmaceuticals. Real-time updates on events, politics, business and more.
Immix Biopharma Subsidiary Nexcella Appoints Henry McKinnell, Jr., former Chairman and CEO of Pfizer Inc., to Board of Directors
LOS ANGELES - Nexcella, Inc., a subsidiary of Immix Biopharma, Inc. , today announced that effective today, Henry A. McKinnell, Jr, Ph.D., former Chairman and Chief Executive Officer of Pfizer Inc.,... | June 13, 2023
Source: marketscreener.com
Immix Biopharma Subsidiary Nexcella Appoints Henry McKinnell, Jr., former Chairman & CEO of Pfizer Inc., to Board of Directors
Dr. McKinnell joins the Nexcella, Inc. Board of Directors with 35 years of experience at Pfizer, Inc., including 6 years as Chairman and Chief Executive OfficerDr. McKinnell is a former... | June 12, 2023
Source: marketscreener.com
Amaran Biotech Introduces New Vanrx Fully-Automated Robotic Aseptic Filling Line
Amaran Biotechnology Inc., a subsidiary of Taiwan's OBI Pharma Inc., today announced that the construction of its fully-automated aseptic filling...
Source: pharmaceuticalonline.com
Amaran Biotech Introduces the First Fully-Automated Robotic Aseptic Filling Line in Taiwan During Bio Asia-Taiwan 2022 7/28-7/31
HSINCHU, July 13, 2022 /PRNewswire/ -- Amaran Biotechnology Inc., a subsidiary of Taiwan's OBI Pharma Inc., today announced that the construction of its fully-automated aseptic filling line and facilities, a first in Taiwan, has been completed. The new facility minimizes the risks of human factors affecting the quality of the pharmaceutical products, and substantially enhances their safety. The project is now entering the final process validation phase of the medium fill procedures. The new ...
Source: philippinetimes.com
Analysis of the Global Antibiotics Partnering Terms and Agreements 2010 to 2022 - Featuring Players Dr. Reddy's Laboratories, Gilead Sciences, NovaMedica & Synthetic Biologics Among Others
/PRNewswire/ -- The "Global Antibiotics Partnering Terms and Agreements 2010 to 2022" report has been added to ResearchAndMarkets.coms offering. The Global...
United States Quretech Bio Basilea Pharmaceutica Laura Wood Paratek Pharmaceuticals Md Anderson Cancer Center
Source: prnewswire.com
Vesigen Therapeutics Appoints Paulash Mohsen as Chief Executive Officer
Vesigen Therapeutics Appoints Paulash Mohsen as Chief Executive Officer - read this article along with other careers information, tips and advice on BioSpace
United Kingdom Quan Lu Gerald Chan Massachusetts Institute Of Technology Optimer Pharmaceuticals Merck Co
Source: biospace.com
Drug, Anti-infective Market Robust Demand Aided Revenue Growth | GlaxoSmithKline, Merck, Pfizer, Novartis AG, Gilead Sciences
Drug, Anti-infective Market Robust Demand Aided Revenue Growth | GlaxoSmithKline, Merck, Pfizer, Novartis AG, Gilead Sciences
Source: sandiegosun.com